We have located links that may give you full text access.
Evaluation Studies
Journal Article
An introduction to instrumental variables--part 2: Mendelian randomisation.
Neuroepidemiology 2010
In the first part of this series, it was highlighted how even though randomised controlled trials can provide robust evidence for therapeutic interventions, for many types of exposure it may not be either practical or ethical to randomise patients to such studies (see part 1). Instrumental variables (IV) analyses have been increasingly employed in recent times in epidemiology to investigate the potential causal effects of an exposure. An IV is a variable that can realistically mimic the treatment allocation process in a randomised study and is assumed to be not directly related to outcome, except through the direct effect of treatment and not related to outcome through either measured or unmeasured confounders. As discussed in the first article, IV analyses can be useful in estimating direct treatment effects provided that the chosen instrument is strong. A particular type of IV analysis where a specific genetic variant has been used as the instrument known as 'Mendelian randomisation' has become increasingly common. The aim of the second part of this statistical primer is to outline the approach to Mendelian randomisation and some of the advantages and disadvantages of this approach.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app